216 related articles for article (PubMed ID: 28497072)
1. Improved
Sinnett SE; Hector RD; Gadalla KKE; Heindel C; Chen D; Zaric V; Bailey MES; Cobb SR; Gray SJ
Mol Ther Methods Clin Dev; 2017 Jun; 5():106-115. PubMed ID: 28497072
[TBL] [Abstract][Full Text] [Related]
2. Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome.
Matagne V; Borloz E; Ehinger Y; Saidi L; Villard L; Roux JC
Neurobiol Dis; 2021 Feb; 149():105235. PubMed ID: 33383186
[TBL] [Abstract][Full Text] [Related]
3. Development of a Novel AAV Gene Therapy Cassette with Improved Safety Features and Efficacy in a Mouse Model of Rett Syndrome.
Gadalla KKE; Vudhironarit T; Hector RD; Sinnett S; Bahey NG; Bailey MES; Gray SJ; Cobb SR
Mol Ther Methods Clin Dev; 2017 Jun; 5():180-190. PubMed ID: 28497075
[TBL] [Abstract][Full Text] [Related]
4. A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome.
Matagne V; Ehinger Y; Saidi L; Borges-Correia A; Barkats M; Bartoli M; Villard L; Roux JC
Neurobiol Dis; 2017 Mar; 99():1-11. PubMed ID: 27974239
[TBL] [Abstract][Full Text] [Related]
5. The Efficacy of a Human-Ready mini
Sadhu C; Lyons C; Oh J; Jagadeeswaran I; Gray SJ; Sinnett SE
Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254921
[TBL] [Abstract][Full Text] [Related]
6. Engineered microRNA-based regulatory element permits safe high-dose miniMECP2 gene therapy in Rett mice.
Sinnett SE; Boyle E; Lyons C; Gray SJ
Brain; 2021 Nov; 144(10):3005-3019. PubMed ID: 33950254
[TBL] [Abstract][Full Text] [Related]
7. Improved survival and reduced phenotypic severity following AAV9/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice.
Gadalla KK; Bailey ME; Spike RC; Ross PD; Woodard KT; Kalburgi SN; Bachaboina L; Deng JV; West AE; Samulski RJ; Gray SJ; Cobb SR
Mol Ther; 2013 Jan; 21(1):18-30. PubMed ID: 23011033
[TBL] [Abstract][Full Text] [Related]
8. Recent endeavors in MECP2 gene transfer for gene therapy of Rett syndrome.
Sinnett SE; Gray SJ
Discov Med; 2017 Oct; 24(132):153-159. PubMed ID: 29272692
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Rett Syndrome-like phenotypes in Mecp2-knockout rats.
Wu Y; Zhong W; Cui N; Johnson CM; Xing H; Zhang S; Jiang C
J Neurodev Disord; 2016; 8():23. PubMed ID: 27313794
[TBL] [Abstract][Full Text] [Related]
10. Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies.
Bailey RM; Rozenberg A; Gray SJ
Brain Res; 2020 Jul; 1739():146832. PubMed ID: 32289279
[TBL] [Abstract][Full Text] [Related]
11. Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome.
Nance E; Kambhampati SP; Smith ES; Zhang Z; Zhang F; Singh S; Johnston MV; Kannan RM; Blue ME; Kannan S
J Neuroinflammation; 2017 Dec; 14(1):252. PubMed ID: 29258545
[TBL] [Abstract][Full Text] [Related]
12. 5-HT
Dai H; Kitami Y; Goto YI; Itoh M
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430502
[TBL] [Abstract][Full Text] [Related]
13. Mirtazapine treatment in a young female mouse model of Rett syndrome identifies time windows for the rescue of early phenotypes.
Flores Gutiérrez J; Natali G; Giorgi J; De Leonibus E; Tongiorgi E
Exp Neurol; 2022 Jul; 353():114056. PubMed ID: 35358499
[TBL] [Abstract][Full Text] [Related]
14. The methyl-CpG-binding domain (MBD) is crucial for MeCP2's dysfunction-induced defects in adult newborn neurons.
Zhao N; Ma D; Leong WY; Han J; VanDongen A; Chen T; Goh EL
Front Cell Neurosci; 2015; 9():158. PubMed ID: 25964742
[TBL] [Abstract][Full Text] [Related]
15. Oligodendrocyte lineage cells contribute unique features to Rett syndrome neuropathology.
Nguyen MV; Felice CA; Du F; Covey MV; Robinson JK; Mandel G; Ballas N
J Neurosci; 2013 Nov; 33(48):18764-74. PubMed ID: 24285883
[TBL] [Abstract][Full Text] [Related]
16. Delayed Ventricular Repolarization and Sodium Channel Current Modification in a Mouse Model of Rett Syndrome.
Cheng H; Charles I; James AF; Abdala AP; Hancox JC
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628543
[TBL] [Abstract][Full Text] [Related]
17. Astrocyte-specific regulation of hMeCP2 expression in Drosophila.
Hess-Homeier DL; Fan CY; Gupta T; Chiang AS; Certel SJ
Biol Open; 2014 Oct; 3(11):1011-9. PubMed ID: 25305037
[TBL] [Abstract][Full Text] [Related]
18. MeCP2 gene therapy ameliorates disease phenotype in mouse model for Pitt Hopkins syndrome.
Dennys CN; Vermudez SAD; Deacon RJM; Sierra-Delgado JA; Rich K; Zhang X; Buch A; Weiss K; Moxley Y; Rajpal H; Espinoza FD; Powers S; Ávila AS; Gogliotti RG; Cogram P; Niswender CM; Meyer KC
Neurotherapeutics; 2024 Jun; ():e00376. PubMed ID: 38876822
[TBL] [Abstract][Full Text] [Related]
19. Novel MECP2 gene therapy is effective in a multicenter study using two mouse models of Rett syndrome and is safe in non-human primates.
Powers S; Likhite S; Gadalla KK; Miranda CJ; Huffenberger AJ; Dennys C; Foust KD; Morales P; Pierson CR; Rinaldi F; Perry S; Bolon B; Wein N; Cobb S; Kaspar BK; Meyer KC
Mol Ther; 2023 Sep; 31(9):2767-2782. PubMed ID: 37481701
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D modulates cortical transcriptome and behavioral phenotypes in an Mecp2 heterozygous Rett syndrome mouse model.
Ribeiro MC; MacDonald JL
Neurobiol Dis; 2022 Apr; 165():105636. PubMed ID: 35091041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
